Поиск
Закладки
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.
Структурные аномалии сердца

Список литературы

  1. Земцовский Э.В., Малев Э.Г. Малые аномалии сердца и диспластические фенотипы: Монография. - СПб.: Изд-во «ИВЭСЭП», 2012. - 160 с.
  2. Erbel R. et al. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases // European heart journal. - 2014. - Т. 35. - №. 41. - С. 2873-2926.
  3. Silvestry F. E. et al. Guidelines for the Echocardiographic Assessment of Atrial Septal Defect and Patent Foramen Ovale: From the American Society of Echocardiography and Society for Cardiac Angiography and Interventions // Journal of the American Society of Echocardiography. - 2015. - Т. 28. - №. 8. - С. 910-958.
  4. Кадурина Т.И., Горбунова В.Н. Дисплазия соединительной ткани. Руководство для врачей. СПб.: ЭЛБИ- СПб, 2009; 704 с.
  5. Нехайчик Т.А. гемодинамическое обеспечение покоя и физической нагрузки у молодых мужчин с ма- лыми аномалиями сердца: дис. канд. мед. наук: 14.00.06 / Т.А. Нехайчик. - Минск, 2009 - 24с
  6. Наследственные болезни: нац. руководство / гл. ред- акад. РАМН Н.П. Бочков, акад. РАМН Е.К. Гинтер, акад. РАМН ВЛ. Пузырев. - М.: ГЭОТАР-Медиа, 2012. - 936 с.
  7. Nishimura, Rick A., et al. “2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.» Journal of the American College of Cardiology 63.22 (2014): 2438-2488.
  8. Vahanian A. et all. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 2012; 33: 2451 - 2496. Или Guidelines on the management of valvular heart disease (ESC/EACTS). European Heart Journal 2012; 19 (33): 2451-2496.
  9. Lang R. M. et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging // Journal of the American Society of Echocardiography. - 2015. - Т. 28. - №. 1. - С. 1-39. e14.
  10. Porter T. R. et al. Guidelines for the cardiac sonographer in the performance of contrast echocardiography: a focused update from the American Society of Echocardiography // Journal of the American Society of Echocardiography. - 2014. - Т. 27. - №. 8. - С. 797-810.
  11. Ghent criteria, De Paepe A. et al., 1996, Loeys B.L., Dietz H. C., Braverman A.C. et al. The revised Ghent no- sology for the Marfan syndrome J Med Genet 2010; 47: 476-485.
  12. Beighton, P. Ehlers-Danlos syndromes: Revised nosology, Villefranche, 1997 / P. Beighton, A. De Paepe, B. Steinmann, P. Tsipouras, R.J. Wenstrup // Am. J. Med. Genet. - 1998. - Vol. 77, № 1. - P. 31-37.
  13. Grahame R. The revised (Brighton 1998) criteria for the diagnosis of benign joint hypermobility syndrome (BJHS). J Rheumatol. 2000; 27: 1777-1779.
  14. Земцовский Э.В. Наследственные нарушения соединительной ткани в кардиологии. Диагностика и лечение: Российские рекомендации (I пересмотр). Рос. кардиолог. общ-во; ком. экспертов. Рос. кард. журнал. 2013; 99(1): 32 с. - Прил. №1.
  15. Национальные рекомендации российского научного медицинского общества терапевтов по диагно- стике, лечению и реабилитации пациентов с дисплазиями соединительной ткани / Члены оргкомите- та Мартынов А.И., Нечаева Г.И. // Медицинский вестник Северного Кавказа. - 2016. - Т. 11, № 1. - С. 2-76.
  16. Наследственные и многофакторные нарушения соединительной ткани у детей. Алгоритмы диагно- стики. Тактика ведения. Проект Российских рекомендаций / Кадурина Т.И., Гнусаев С.Ф., сопредседа- тели рабочей группы // Медицинский вестник Северного Кавказа. - 2015. - Т. 10, № 1. - С. 5-35.
  17. Диагностика и лечение наследственных и мультифакториальных нарушений соединительной ткани. Национальные клинические рекомендации / Минск: «Профессиональные издания», 2015. - 47с.
  18. Мартынов, А.И. Диагностика и тактика ведения пациентов с дисплазией соединительной ткани в ус- ловиях первичной медико-санитарной помощи: методические рекомендации для врачей / А. И. Мар- тынов, В. М. Яковлев, Г. И. Нечаева [и др.]. - Омск. - 2013. - 133 с.
  19. Нечаева, Г. И. Выявление и тактика ведения пациентов с недифференцированной дисплазией соеди- нительной ткани: метод. рекомендации для врачей / Г. И. Нечаева, В. П. Конев, И. В. Друк [и др.] ; под ред. акад. А. И. Мартынова. - М. - РГ ПРЕ100, 2011. - 52 с.
  20. Сторожаков Г.И. Болезни клапанов сердца / Сторожаков Г.И., Г.Е. Гендлин, О.А. Миллер. - М., Практика, 2012 - 200 с.
  21. Homma S, Sacco RL. Patent foramen ovale and stroke. Circulation 2005; 112: 1063-72.
  22. Meissner I. et al. Patent foramen ovale: innocent or guilty?: evidence from a prospective population-based study // Journal of the American College of Cardiology. - 2006. - Т. 47. - №. 2. - С. 440-445.
  23. Petty GW, Khandheria BK, Meissner I, et al. Population-based study of the relationship between patent foramen ovale and cerebrovascular ischemic events. Mayo Clin Proc. 2006; 81: 602—608.

  1. Di Tullio MR, Sacco RL, Sciacca RR, Jin Z, Homma S. Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. J Am Coll Cardiol. 2007; 49: 797— 802.
  2. Онищенко Е. Ф. Открытое овальное окно и инсульт в клинической практике // СПб.: ЭЛБИ-СПб. - 2005. - Т. 192.
  3. Davison P, Clift PF, Steeds RP. The role of echocardiography in diagnosis, monitoring closure and post- procedural assessment of patent foramen ovale. Eur J Echocardiogr. 2010; 11(10): i27-34
  4. Calvert PA, Rana BS, Kydd AC, Shapiro LM. Patent foramen ovale: anatomy, outcomes, and closure. Nat Rev Cardiol. 2011; 8(3): 148-60.
  5. Guercini F. et al. Cryptogenic stroke: time to determine etiology // Journal of Thrombosis and Haemostasis. - 2008. - Т. 6. - №. 4. - С. 549-554
  6. Palomeras S. E. et al. [Cryptogenic infarct. A follow-up period of 1 year study] // Neurologia (Barcelona, Spain). - 2009. - Т. 24. - №. 5. - С. 304-308
  7. Alsheikh-Ali A. A., Thaler D. E., Kent D. M. Patent Foramen Ovale in Cryptogenic Stroke Incidental or Pathogenic? // Stroke. - 2009. - Т. 40. - №. 7. - С. 2349-2355.
  8. Иваницкий А.В., Голухова Е.З., Косенко А.И. Открытое овальное окно: роль в патогенезе ряда невроло- гических заболеваний и методы их лечения // Журнал неврологии и психиатрии, 2004. - № 5. - С. 65-68.
  9. Суслина, З.А. Патогенетическая гетерогенность ишемического инсульта и открытое овальное отвер- стие / З.А. Суслина, А.В. Фонякин, А.О. Чечеткин и др. // Клиническая неврология. - 2008. - №3 (Т.2). - С.4-7.
  10. Diener H.C. Rationale, objectives and design of a secondary stroke prevention study of dabigatran etexilate versus acetylsalicylic acid in patients with embolic stroke of undetermined source (RE-SPECT-ESUS). Abstracts of the European Stroke Conference. Cerebrovasc Dis. 2014; 37(suppl 1): 1-2.
  11. Srivastava T. N., Payment M. F. Paradoxical Embolism—Thrombus in Transit through a Patent Foramen Ovale // New England Journal of Medicine. - 1997. - Т. 337. - №. 10. - С. 681-681
  12. Hart R. G. et al. Embolic strokes of undetermined source: the case for a new clinical construct // The Lancet Neurology. - 2014. - Т. 13. - №. 4. - С. 429-438.
  13. Di Tullio M., Sacco R.L., Venketasubramanian N. et al. Comparison of diagnostic techniques for the detection of a patent foramen ovale in stroke patients. Stroke 1993; 24: 10201024.
  14. Cramer SC, Rordorf G, Maki JH, et al. Increased pelvic vein thrombi in cryptogenic stroke: results of the Paradoxical Emboli from Large Veins in Ischemic Stroke (PELVIS) study. Stroke. 2004; 35(1): 46-50.
  15. Scarvelis D., Wells P. S. Diagnosis and treatment of deep-vein thrombosis // Canadian Medical Association Journal. - 2006. - Т. 175. - №. 9. - С. 1087-1092.
  16. Meier B. Closure of patent foramen ovale: technique, pitfalls, complications, and follow up // Heart. - 2005. - Vol.91. - P.444-448.
  17. Overell J. R., Bone I., Lees K. R. Interatrial septal abnormalities and stroke A metaanalysis of case-control studies // Neurology. - 2000. - Т. 55. - №. 8. - С. 1172-1179.
  18. Caputi L, Usai S, Carriero MR, et al. Microembolic air load during contrast- transcranial Doppler: a trigger for migraine with aura? Headache. 2010; 50(8): 1320-7.
  19. Karttunen, V. Factor V Leiden and prothrombin gene mutation may predispose to paradoxical embolism in subjects with patent foramen ovale / V. Karttunen, L. Hiltunen, V. Rasi et al. // Blood. Coagul. Fibrinolysis. - 2003. - Vol. 14. - P. 261-268.
  20. Bezzi, G. Leiden mutation and patent foramen ovale in ischemic stroke / G. Bezzi, W. Bolzani, V. Compagnoni et al. // eurol. Sci. - 2002. - Vol. 23. - P. 229-231.
  21. Carod, F. Thrombophilia and patent foramen ovale in young stroke patients / F. Carod, N. S. Vilela, D. Portugal // Neurol. - 2006. - Vol. 21. - P. 710-716.
  22. Sastry, S. Young adult myocardial infarction and ischemic stroke: the role of paradoxical embolism and thrombophilia (The YAMIS Study) / S. Sastry, G. Ridding, J. Morris et al. // J. Amer. Coll. Cardiol. - 2006. - Vol. 48. - P. 686-691.
  23. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association / Е. C. Jauch et al. // Stroke. 2013; 44: 870-947.
  24. Kernan W., Ovbiagele B., Black H., et al. Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack. Stroke 2014; 45: 2160-236.
  25. Burchell HB, Helmholz HF Jr, Wood EH. Reflex orthostatic dyspnea associated with pulmonary hypertension. Am J Physiol. 1949; 159: 563-564.
  26. Cheng T.O. et al. Platypnea-orthodeoxia syndrome: etiology, differential diagnosis, and management. Cathet Cardiovasc Interv. 1999; 47: 64-66.
  27. Medina A, Suarez de Lezo J, Caballero E, et al. Platypnea-orthodeoxia due to aortic elongation. Circulation. 2001; 104: 741
  28. Pinto F.J. When and how to diagnose patent foramen ovale / F.J. Pinto. - Heart. 2005 Apr; 91(4): 438-440.
  29. Sommer R.J., Hijazi Z.M., Rhodes J.F. Pathophysiology of Congenital Heart Disease in the Adult. Part I: Shunt Lesions // Circulation. - 2008. - Vol. 117. - P. 1090-1099.
  30. Torti SR, Billinger M, Schwerzmann M, et al. Risk of decompression illness among 230 divers in relation to the presence and size of patent foramen ovale. Eur Heart J 2004; 25: 1014-20.
  31. Шарыкин А.С. Открытое овальное окно - малая аномалия сердца или порок? Педиатрия. 2013; 01: 24 - 27
  32. Mojadidi M. K. et al. Diagnostic Accuracy of Transesophageal Echocardiogram for the Detection of Patent Foramen Ovale: A Meta-Analysis // Echocardiography. - 2014. - Т. 31. - №. 6. - С. 752-758.
  33. Buchholz S. et al. Diagnosis and management of patent foramen ovale // Postgraduate medical journal. - 2012. - С. Postgradmedj 2011-130368
  34. Tanaka J. et al. Classification of Patent Foramen Ovale Tunnel Morphology; A Real Time 3-Dimentional Transesophageal Echocardiographic Study // Circulation. - 2012. - Т. 126. - №. 21 Supplement. - С. A16788.
  35. Newton J. D. et al. Intracardiac echocardiography for patent foramen ovale closure: justification of routine use // JACC: Cardiovascular Interventions. - 2009. - Т. 2. - №. 4. - С. 369-369.
  36. Yared K. et al. Echocardiographic assessment of percutaneous patent foramen ovale and atrial septal defect closure complications / Circ Cardiovasc Imaging. 2009, Mar; 2(2): 141-9.
  37. Gonzalez-Alujas T. et al. Diagnosis and quantification of patent foramen ovale. Which is the reference technique? Simultaneous study with transcranial Doppler, transthoracic and transesophageal echocardiography // Revista Espanola de Cardiologia (English Edition). - 2011. Т. 64. - №. 2. - С. 133-139.
  38. Шарыкин А.С. Врожденные пороки сердца / Руководство для педиатров, кардиологов, неонатологов. - 2-е изд. - М: БИНОМ, 2009. - С. 111-122.
  39. Touboul P. J. et al. Common carotid artery intima-media thickness and ischemic stroke subtypes: the GENIC casecontrol study. The GENIC Investigators // Circulation. - 2000. - Т. 102. - №. 3. - С. 313-8.
  40. Суслина З.А., Верещагин Н.В., Пирадов М.А. Подтипы ишемических нарушений мозгового кровообра- щения: диагностика и лечение. Consilium Medicum. 2001; 3(5): 218-21
  41. Adams H. P. et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment // Stroke. - 1993. - Т. 24. - №. 1. - С. 35-41.
  42. Finsterer J. Management of cryptogenic stroke // Acta Neurol Belg. - 2010. - Т. 110. - №. 2. - С. 135-47.
  43. Arquizan C., Coste J. Touboul P-J. et al. Is Patent Foramen Ovale a Family Trait? Stroke 2001; 32:1563-1566.
  44. Thaler DE, Saver JL. Cryptogenic stroke and patent foramen ovale / Curr Opin Cardiol. - 2008. - Vol. 23, № 6. - Р. 537-44.
  45. Messe S.R. et all. Recurrent Stroke With Patent Foramen Ovale and Atrial Septal Aneurysm // NEUROLOGY 2004; 62: 1042-1050
  46. Arauz A. et al. Long-term risk of recurrent stroke in young cryptogenic stroke patients with and without patent foramen ovale // International Journal of Stroke. - 2012. - Т. 7. - №. 8. С. 631-634.
  47. Mas JL, Arquizan C, Lamy C. et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med. 2001; 345: 1740-1746.
  48. Lamy, C. et all. Clinical and Imaging Findings in Cryptogenic Stroke Patients With and Without Patent Foramen Ovale The PFO-ASA Study // Stroke. - 2002; 33: 706-711
  49. Katsanos A. H. et al. Recurrent Stroke and Patent Foramen Ovale A Systematic Review and Meta-Analysis // Stroke. - 2014. - Т. 45. - №. 11. - Р. 3352-3359.
  50. Whitlock R. P. et al. Antithrombotic and thrombolytic therapy for valvular disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines // CHEST Journal. - 2012. - Т. 141. - №. 2_suppl. С. e576S-e600S.
  51. Messe SR, Gronseth G, Kent DM, Kizer JR, Homma S, Rosterman L, Kasner SE. Practice advisory: Recurrent stroke with patent foramen ovale (update of practice parameter): Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2016 Aug 23; 87(8): 815-21.
  52. Furlan AJ, Reisman M, Massaro J, et al; CLOSURE I Investigators. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med 2012; 366: 991-999.
  53. Meier B, Kalesan B, Mattle HP, et al; PC Trial Investigators. Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J ed 2013; 368: 1083-1091.
  54. Carroll JD, Saver JL, Thaler DE, et al; RESPECT Investigators. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med 2013; 368: 1092-1100.
  55. Sacco R. L. et al. Comparison of warfarin versus aspirin for the prevention of recurrent stroke or death: subgroup analyses from the Warfarin-Aspirin Recurrent Stroke Study // Cerebrovascular diseases (Basel, Switzerland). - 2006. - Т. 22. - №. 1. - С. 4-12.
  56. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP; PFO in Cryptogenic Stroke Study (PICSS) Investigators. Effect of medical treatment in stroke patients with patent foramen ovale: Patent Foramen Ovale in Cryptogenic Stroke Study. Circulation 2002; 105: 2625-2631.
  57. Mohr J, Thompson JLP, Lazar RM, et al; the Warfarin-Aspirin Recurrent Stroke Study Group. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 2001; 345: 1444-1451.
  58. Shariat A, Yaghoubi E, Farazdaghi M, Aghasadeghi K, Borhani Haghighi A. Comparison of medical treatments in cryptogenic stroke patients with patent foramen ovale: a randomized clinical trial. J Res Med Sci 2013; 18: 94-98.
  59. Hara H, Virmani R, Ladich E et al. Patent foramen ovale: Curent pathology, pathophysiology, and clinical status. J Am Coll Card 2005; 46: 1768-76.
  60. Silver MD, Dorsey JS. Aneurysms of the septum primum in adults. Arch Pathol Lab Med 1978; 102: 62-5.
  61. Жерко, О.М. Малые аномалии сердца у детей: учебно-методическое пособие / О.М. Жерко; Бел. мед. акад. Последиплом. Образования. - Минск: БелМАПО, 2007. - 39с.
  62. Шарыкин, А. С. Открытое овальное окно - малая аномалия сердца или порок? // А. С. Шарыкин/ Cоnsiliummedicum, педиатрия. - № 1. - 2013. - с.
  63. Burger AJ, Sherman HB, Charlamb MJ. Low incidence of embolic strokes with atrial septal aneurysms: A prospective, long-term study. AmHeartJ. 2000; 139 (1 Pt 1): 149-52.
  64. Nihoyannopoulos P, Kisslo J. Echocardiography. SpringerVerlag; 2009: 504 р.
  65. Рыбакова М.К., Алехин М.Н., Митьков В.В.Практическое руководство по ультразвуковой диагностике. Эхокардиография. Изд. 2-е, испр. и доп. М.: Издательский дом Видар-М, 2008. — 544 с.
  66. Кужель, Г.В. Вопросы диагностики открытого овального окна // Д. А. Кужель, Г.В. Матюшин, Е.А. Сав- ченко / ^бирское медицинское обозрение. - № 1. - 2014. - с. 70 - 75.
  67. Hanley P.C. et al. Diagnosis and classification of atrial septal aneurysm by two- dimensiona echocardiography: report of 80 consecutive cases. J Am coll cardiol. 1985; 6: 137082.
  68. Alexander Olivares-Reyes, MD, Samuel Chan, MD, Eliot J. Lazar, MD, Kishore Bandlamudi, RDCS, Venkateswara Narla, MD, Kenneth Ong, MD et al. Atrial septal aneurysm: a new classification in two hundred five adults. J Am Soci Echocardiography. 1997, July; 6: 644-56.
  69. Roudant R, Gosse R, Chague E, Dehant P, Choussat A, Dallochio M. Clinical and echocardiographic feature of the aneurysm on the atrial septum in infants and adults: experiences with 44 cases. Echocardiography. 1989; 6: 357-62.
  70. Pearson A, Nagelhout D, Castello R, Gomez CR, Labovitz AJ. Atrial septal aneurysm and stroke: a transesophageal echocardiographic study. J Am CollCardiol. 1991; 18: 122 3-9.
  71. Jatav RK et al. Atrial septal aneurysm in adult patients: spectrum of clinical, echocardiographic presentation and to propose a new classification on the basis of trans-thoracic- two-dimensional echocardiography Int J Res Med Sci. 2014 May; 2(2): 708-717.
  72. MuggeA, Daniel WG, Angermann C, et al. Atrial septal aneurysm in adult patients. A multicenter study using transthoracic and transesophageal echocardiography. Circulation. 1995; 91(11): 2785-92.
  73. Ghosh S, Ghosh AK, Ghosh SK. Patent foramen ovale and atrial septal aneurysm in cryptogenic stroke. Postgrad Med J. 2007; 83(977): 173-7.
  74. Gallet B, Malergue MC, Adams C, et al. Atrial septal aneurysm — a potential cause of systemic embolism. An echocardiographic study. Br Heart J. 1985; 53(3): 292-7.
  75. Agmon Y, Khandheria BK, Meissner I, et al. Frequency of atrial septal aneurysms in patients with cerebral ischemic events. Circulation. 1999; 99(15): 1942-4.
  76. Janion M, Kurzawski J, Sielski J, Ciuraszkiewicz K, Sadowski M, Radomska E. Dispersion of P wave duration and P wave vector in patients with atrial septal aneurysm. Europace. 2007; 9(7): 471-4.
  77. Mattioli AV, Bonetti L, Aquilina M et al. The association between atrial septal aneurysm and mitral valve prolapse in patients with recent stroke and normal carotid arteries. Ital Heart J. 2003 Sep; 4(9): 602-6.
  78. Garg R, Khaj a A, Madsen R et al. Observer variation in the echocardiographic measurement of maximum atrial septal excursion: a comparison of M-mode with two- dimensional or transesophageal echocardiography. Echocardiography. 2009; 26(10): 1122-6.
  79. Bakalli A, Kamberi L, Pllana E, Gashi A. Atrial septal aneurysm associated with additional cardiovascular comorbidities in two middle age female patients with ECG signs of right bundle branch block: two case reports. Cases J. 2008; 1(1): 51.
  80. Rahimtoola SH. Presence of patent foramen ovale (PFO). Foreword. CurrProblCardiol. 2009 Oct; 34(10): 481.
  81. Seiler C. How should we assess patent foramen ovale? // Heart. - 2004. - Vol. 90. - P. 1245-1247.
  82. Roberts WC. Aneurysm (redundancy) of the atrial septum (fossa ovale membrane) and prolapse (redundancy) of the mitral valve. Am J Cardiol. 1984; 54: 1153-1154.
  83. Iliceto S, Papa A, Sorino M, Rizzon P. Combined atrial septal aneurysm and mitral valve prolapse: detection by two-dimensional echocardiography. Am J Cardiol. 1984; 54: 1151-1154.
  84. Abinader EG, Rokey R, Goldhammern E, Kuo LC, Said E. Prevalence of atrial septal aneurysm in patients with mitral valve prolapse. Am J Cardiol. 1988; 62: 1139-1140.
  85. Rahko PS, Xu QB. Increased prevalence of atrial septal aneurysm in mitral valve prolapse. Am J Cardiol. 1990; 62: 235—237.
  86. Mastroroberto P, Chello M, Zofrea S, et al. Combined mitral valve prolapse and atrial septal aneurysm. A cause for embolic events. J Cardiovasc Surg. 1994; 35(6): 507-9.
  87. Freed L.A., Levy D, Levine RA et al. Mitral valve prolapse and atrial septal aneurysm: an evaluation in the Framingham Heart Study. Am J Cardiol. 2002, Jun 1; 89(11): 1326-9.
  88. Lee JY, Song JK, Song JM, et al. Association between anatomic features of atrial septal abnormalities obtained by omni-plane transesophageal echocardiography and stroke recurrence in cryptogenic stroke patients with patent foramen ovale. Am J Cardiol. 2010; 106(1): 129-34.
  89. Rigatelli G, Dell’Avvocata F, Braggion G, et al. Persistent venous valves correlate with increased shunt and multiple preceding cryptogenic embolic events in patients with PFO: an intracardiac echo study. Catheter CardiovascInterv 2008; 72: 973e6.
  90. Wahl A, Krumsdorf U, Meier B, et al. Transcatheter treatment of atrial septal aneurysm associated with patent foramen ovale for prevention of recurrent paradoxical embolism in high- risk patients. J Am Coll Cardiol. 2005; 45(3): 377-80.
  91. Greutmann M, Greutmann-yantiri M, Kretschmar O, et al. Percutaneous PFO closure with Amplatzer PFO occluder: predictors of residual shunts at 6 months follow- up. CongenitHeartDis. 2009; 4(4): 252-7.
  92. Яровая И.М. Органные особенности гистологического строения венозных сосудов и возрастные их изменения // В кн.: Очерки по гемодинамической перестройке сосудистой стенки. - М.: «Медицина», 1971. - С.45-107
  93. Тен С.А. К морфологии клапана нижней полой вены человека // 9-ый Всесоюз. съезд анатомов, гисто- логов и эмбриологов: тез.докл. - Минск, 1981. - С.381
  94. Ухов Ю.И., Колобаев А. В. Устьевой клапан нижней полой вены - пятый клапан сердца (?) // Арх. анато- мии, гистологии и эмбриологии. - 1982. - Т. 82, № 3. - С. 95 - 100.
  95. G. Laguna, N. Arce, M. Blanco Giant Chiari Network, Foramen Ovale, and Paradoxical Embolism Rev EspCardiol. 2015; 68(3): 250
  96. Schneider B., Hofmann T., Justen M.H., Meinertz T. Chiari’s network: normal anatomic variant or risk factor for arterial embolic events // J. Am. Coll. Cardiol. 1995. V. 26. No. 1. P. 203-210.
  97. Юдина О.А. Морфологическая и клиническая характеристика малых аномалий сердца: автореф. к.м.н. (специальность 14.00.15 - патологическая анатомия; 14.00.06 - кардиология). - Минск, 2009. - 25 с.
  98. Алехин М. Н. Эхокардиографическая диагностика сети Хиари / Алехин М. Н., Докина Е. Д. // Ультра- звуковая и функциональная диагностика. — 2014. — № 5. - С. 119— 127.
  99. Yater W.M. Variations and anomalies of the venous valves of the right atrium of the human heart // Arch. Pathol. 1929. V. 7. P. 418-441.
  100. Orbison J.L. Thrombosis of anomalous chordae in the right atrium (Chiari’s network) // Am. HeartJ. 1949. V. 37. No. 1.P. 119-122.
  101. Chevallier S., Cook S. Shoulder pain after PFO closure: look at the Chiari network. - 2011. - [Electronic resource]. - Mode of access: http: // www.revespcardiol.org/en/giant-chiari- network-foramen-оvale/ articulo/90387090/- Date of access: 23.01.2016.
  102. Rigatelli G. et al. Migraine-patent foramen ovale connection: role of prominent eustachian valve and large Chiari network in migrainous patients. Am J Med Sci. 2008; 336(6): 458-461.
  103. Payne DM, Baskett RJF, Hirsch GM. Infectious endocarditis of a Chiari network. Ann ThoracSurg2003; 76: 1303-1305.
  104. Mousavi N., Bhagirath K., Ariyarajah V. et al. Chiari network endocarditis: not just an innocent bystander // Echocardiography. 2008. V. 25. No. 6. P. 642-645.
  105. Latif F., Peyton M., Laszik Z., Sivaram C.A. Infective endocarditis of a papillary fibroelastoma on Chiari network of right atrium: a case report // J. Am. Soc. Echocardiogr. 2008. V. 21. No. 2.P. 188.e3-188.e4.
  106. Koz C., Yokusoglu M., Baysan O., Uzun M. Giant Chiari network mimics intracardiac tumor in a case of neurofibromatosis // Int. J. Cardiol. 2008. V. 130. No. 3.P. 488-489.
  107. Loukas M., Sullivan A., Tubbs R.S. et al. Chiari’s network: review of the literature // Surg. Radiol. Anat. 2010. V. 32. No. 10. P. 895-901.
  108. Helwig F.C. The frequency of anomalous reticula in the right atrium of the human heart “Chiari network”. Report of eight cases // Am. J. Pathol. 1932. V. 8. No. 1. P. 73-79.
  109. Yater W.M. The paradox of Chiari’s network. Review and report of a case of Chiari’s network ensnaring a large embolus. Am Heart J 1936; 11: 542—553.
  110. Yuen S.T., Dickens P. Sudden death from secondary massive pulmonary embolism derived from marrow emboli trapped by Chiari’s network. Forensic SciInt 1992; 52: 211—214.
  111. Powell E.D., Mullaney J.M. The Chiari network and the valve of the inferior vena cava // Brit. Heart J. 1960. V. 22. P. 579-584.
  112. Benbow E.W., Love E.M., Love H.G., MacCallum P.K. Massive right atrial thrombus associated with a Chiari network and a Hickman catheter // Am. J. Clin. Pathol. 1987. V. 88. No. 2. P. 243-248.
  113. Prajapat L., Ariyarajah V., Spodick D.H. Abnormal atrial depolarization associated with Chiari network? // Cardiology. 2007. V. 108. No. 3. P. 214-216.
  114. Alegma-Barrero E, Alegma-Barrero A, GaviraGуmezJJ, Rabago Juan-AracilG.Chiari’s Network and Paroxysmal Atrial Fibrillation. Rev EspCardiol. 2011; 64(8): 727-728.
  115. Teo E.Y., Ittleman F., Hamlin M.P. A Chiari network and difficult cannulation of the coronary sinus for retrograde perfusion // Anesth. Analg. 2010. V. 111. No. 1. P. 79-81.
  116. Aydin A., Gurol T, Yilmazer MS, Dagdeviren B. Catheter entrapment around the Chiari network during percutaneous atrial septal defect closure. [cited 2012 Oct 15]. Anadolu Kardiyoloji Dergisi. doi: http: // dx.doi.org/10.5152/akd.2011.047. [PubMed]
  117. Goldschlager A., Goldschlager N., Brewster H., Kaplan J. Catheter entrapment in a Chiari network involving an atrial septal defect // Chest. 1972. V. 62. No. 3. P. 345-346.
  118. Salmeron O., Zarco P., Nunez L. Unusual complication of right catheterization: hooking of the catheter in Chiari’s network // Arch. Inst. Cardiol. Mex. 1966. V. 36. No. 4. P. 387-390.
  119. Jain A. et al. Persistens Eusthachian valve in adults - a cadaveric study. International Journal of Basic and Applied Medical Sciences. 2013; 3 (3): 132-137.
  120. Limacher MC, Gutgesell HP, Vick GW, Cohen MH, Huhta JH. Echocardiographic anatomy of the Eustachianvalve. Am J Cardiol 1986; 57: 363-5.
  121. Asirdizer M, Tatlisumak E. The role of eustachian valve and patent foramen ovale in sudden death. J ClinForensic Med 2006; 13: 262-7.
  122. Gulel O. et al. Unusual Elongation of the Eustachian Valve Int Heart J 2007; 48: 113116)
  123. Ультразвуковая семиотика и диагностика в кардиологии детского возраста [Электронный ресурс].-Режим доступа: http: // www.mks.ru/library/books/bum/kniga01/glava_13.htm. - Дата доступа: 10.01.2016
  124. 3D echocardiography: the art of defining cardiac morphology [Electronic resource]. - Mode of access: http: // www.3dechocardiography.com/Cortriatriatum_Dexter.html. - Date of access: 24.01.2016.
  125. Vale TA, Newton JD, Orchard E et al. Prominence of the Eustachian valve in paradoxical embolism. Eur J Echocardiogr. 2011; 12(1): 33-6.
  126. Schuchlenz HW, Saurer G, Weihs W, Rehak P. Persisting eustachian valve in adults: relation to patent foramen ovale and cerebrovascular events. J Am SocEchocardiogr 2004; 17: 231-3.
  127. Barriales Alvarez V, Alvarez Tamargo JA, Garcia Aguado M, Martinez de Salinas ES. Floating thrombi on the eustachian valve as complication of venous thromboembolic disease. Med Clin (Barc) 2002; 119: 479. (Spanish).
  128. Jolly N, Kaul UA, Khalilullah M. Right atrial thrombus over eustachian valve - successful lysis with streptokinase. Int J Cardiol 1991; 30: 354-6.
  129. Maddury J. et al. Thrombus on the Eustachian valve leading to recurrent pulmonary embolism: A rare problem requiring aggressive management. The Canadian Journal of Cardiology 25(2): 422-423.
  130. Suchato C, Kitiyakara K, Arkrawong K. Suprahepatic membranous obstruction of inferior vena cava. J CanAssocRadiol 1977; 28: 148-9.
  131. Schmid E, Scheule A, Locke A, Rosenberger P. Echocardiographic-guided placement of venous cannula due to inferior vena cava obstruction through a large eustachian valve. AnesthAnalg. 2010 Jul; 111(1): 76-8.
  132. Kokkonen L, Anttonen O, Voutilainen S, Honkanen T, Talvensaari T. Central cyanosis and persisting Eustachian valve. Duodecim 2005; 121: 311-3.
  133. Condoluci C, di Donato RM, Marcelletti C, Guccione P. Central cyanosis in a newborn infant due to a prominence of the eustachian valve. G ItalCardiol 1994; 24: 151-4. (Italian)
  134. Bonde P, Sachithanandan A, Graham AN, Richardson SG, Gladstone DJ. Right atrial myxoma arising from the Eustachian valve in a patient with colonic polyposis. J Heart Valve Dis 2002; 11: 601-2.
  135. Shigemitsu O, Hadama T, Mori Y, Miyamoto S, Sako H, Uchida Y. Surgical treatment of right atrial papillary fibroelastoma, originated from the eustachian valve - a case report. Nippon KyobuGekaGakkaiZasshi 1995; 43: 403-6. (Japanese)
  136. Nkomo VT, Miller FA. Eustachian valve cyst. J Am SocEchocardiogr 2001; 14: 12246.
  137. Pellicelli AM, Pino P, Terranova A, D’Ambrosio C, Soccorsi F. Eustachian valve endocarditis: a rare localization of right side endocarditis. A case report and review of the literature. Cardiovasc Ultrasound 2005; 3: 30.(Review)
  138. San Roman JA, Vilacosta I, Sarria C, Garcimartin I, Rollan MJ, Fernandez-Aviles F. Eustachian valve endocarditis: Is it worth searching for? Am Heart J 2001; 142: 1037-40.
  139. Halimi F, Hidden-Lucet F, Tonet J, Fontaine G, Frank R. Radiofrequency catheter ablation of common atrial flutter: role of the eustachian valve. J Interv Card Electrophysiol 1999; 3: 169-72.
  140. Nakagawa H, Lazzara R, Khastgir T, et al. Role of the tricuspid annulus and the eustachian valve/ridge on atrial flutter. Relevance to catheter ablation of the septal isthmus and a new technique for rapid identification of ablationsuccess. Circulation 1996; 94: 407-24.
  141. Schrem SS, Freedberg RS, Gindea AJ, Kronzon I. The association between unusually large eustachian valves and atrioventricular prolapse. Am Heart J. 1990; 120: 204—206.
  142. Yavuz T. et al. Giant Eustachian Valve: With Echocardiographic Appearance of Divided Right Atrium. Texas Heart Institute Journal 2002; 29(4): 336-338
  143. Martinez-Quintana E, Rodriguez-Gonzalez F, Marrero-Santiago H, Santana- Montesdeoca J, Lopez-Gude MJ. Cortriatriatum dexter versus prominent Eustachian valve in an adult congenital heart disease patient. Congenit Heart Dis. 2013 Nov-Dec; 8(6): 89-91. Epub 2012 Apr 2.
  144. Roberson, David A. et al. Double Atrial Septum with Persistent Interatrial Space: Echocardiographic Features of a Rare Atrial Septal Malformation. Journal of the American Society of Echocardiography. 2006; 19 (9): 1175 - 1181.
  145. Modi K., Reddy P., Madhusudanannair V. Diagnosis of a Very Rare Variant of Cor Triatriatum Dexter by Contrast Echocardiography: A Case Report Echocardiography 2009 26(2), 220-223.
  146. Seyfert H., Bohlscheid V., Bauer B. Double atrial septum with persistent interatrial space and transient ischaemic attack. European Heart Journal - Cardiovascular Imaging 2008; 9 (5): 707-708.
  147. Javois A. J., Roberson D. A. Unusual Atrial Septal Anatomy Resulting in an Interatrial Chamber: The True Triatrial Heart? Pediatr Cardiol 2007; 28: 224 - 228.
  148. Becker A, Buss M, Sebening W, Meisner H, Dohlemann C. Acute inferior cardiac inflow obstruction resulting from inadvertent surgical closure of a prominent Eustachian valve mistaken for an atrial septal defect. PediatrCardiol 1999; 20: 155-7.
  149. Tarnowska A, Werner B, Godlewski K. Difficulties in transcutaneous closure of atrial septal defect - persistent Eustachian valve. Kardiol Pol 2003; 59: 258-60.
  150. Onorato E, Pera IG, Melzi G, Rigatelli G. Persistent redundant Eustachian valve interfering with Amplatzer PFO occluder placement: anatomico-clinical and technical implications. Catheter CardiovascInterv 2002; 55: 521-4.
  151. Ugar O, Canbay A, Diker E, Aydo du S. Long Eustachian valve interfering with the access to coronary sinus during biventricular pacemaker implantation. AnadoluKardiyolDerg. 2010 Apr; 10(2): 185-6.
  152. Scacciatella P, Butera G, Meynet I, et al. Percutaneous Closure of Patent Foramen Ovale in Patients with Anatomical and Clinical High-Risk Characteristics: Long-Term Efficacy and Safety. J IntervCardiol. 2011 Oct; 24(5): 477-84.
  153. Ho S.Y. Anatomy of the mitral valve. Heart 2002; 88; 5-10.
  154. Grewal, J. Mitral annular dynamics in myxomatous valve disease: new insights with real-time 3-dimensional echocardiography / J. Grewal, R. Suri, S. Mankad et al. // Circulation. - 2010. - V. 121. - P. 1423-31.
  155. Barlow, J.B. The significance of late systolic murmurs and mid-late systolic clicks / J.B. Barlow, W.A. Pocock // Md State Med J. - 1963. - V. 12. - P. 76-7.
  156. Carpentier, A. Fibroelastic dysplasia of the mitral valve. An anatomical and clinical entity [abstract] / A. Carpentier, F. Lacour-Gayet, J.P. Camilleri, C.H. DuBost // Circulation. - 1980. - V. 62. - Suppl ll. - P. 111.
  157. Freed, L.A. A locus for autosomal dominant mitral valve prolapse on chromosome 11p15.4 / L.A. Freed, J.S. Acierno, D. Dai et al. // American journal of human genetics. - 2003. V. 72. - № 6. - P. 1551-9.
  158. Nesta, F. New locus for autosomal dominant mitral valve prolapse on chromosome 13: clinical insights from genetic studies / F. Nesta, M. Leyne, C. Yosefy et al. // Circulation. - 2005. V. 112. - № 13. - P. 2022-30.
  159. Kyndt, F. Mutations in the gene encoding filamin A as a cause for familial cardiac valvular dystrophy / F. Kyndt, J.P. Gueffet, V. Probst et al. // Circulation. - 2007. - V.115. - № 1. - P. 40-9.
  160. 183 Рудой, А.С. Роль TGFP-индукции и гастроинтестинальных миофибробластов в патоморфогенезе хронического гастрита у пациентов с синдромом Марфана и марфаноподобными состояниями / А.С. Рудой, Т.А. Летковская, А.М. Урываев, И.П. Реуцкий // Экспериментальная и клиническая гастроэнте- рология. - 2016. - № 6. - С. 14-18.
  161. Громова О.А. Молекулярные механизмы воздействия магния на дисплазию соединительной ткани. Диспл. соединит. ткан. 2008. №1. С. 25-34.
  162. Клеменов А.В. Пролапс митрального клапана. Изд. 2-е, перераб. и доп. М.: ИД Медпрактика-М. 2005. - 40 с.
  163. Schneider, A. Definition and diagnosis of mitral valve prolapse [Электронный ресурс] / A. Schneider, M.Sorrentino // 2013. - Режим доступа: http: // medicine.ucsf.edu/education/resed/Chiefs_cover_sheets/ mvp.pdf.
  164. Shah, P.M. Current concepts in mitral valve prolapse - diagnosis and management / P.M. Shah // J Cardiol. - 2010. - V. 56. - № 2. - P. 125-33.
  165. Bonow R.O. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine / R.O. Bonow, D.L. Mann, D P. Zipes, P. Libby. - 9th ed. - Philadelphia, 2011. - 2048
  166. Bonow R.O. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines / R.O. Bonow, B.A. Carabello, K. Chatterjee et al. // J Am Coll Cardiol. - 2008. - V. 52. - P. e1-142.
  167. Otto, C.M. Valvular Heart Disease / C.M. Otto, R.O. Bonow // Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine / R.O. Bonow, D.L. Mann, D.P. Zipes, P. Libby. - 9th ed. - Philadelphia: Elsevier, 2011. - P. 1468-1539.
  168. Otto, C.M. Valvular Heart Disease: A Companion to Braunwald’s Heart Disease / C.M. Otto, R.O. Bonow. - 3th ed. - Philadelphia: Elsevier, 2009. - 452 p.
  169. Grau, J., Pirelli, L., Yu, P.-J., Galloway, A. and Ostrer, H. The genetics of mitral valve prolapse. Clinical Genetics. 2007. 72: 288-295.
  170. Pellerin, D. Degenerative mitral valve disease with emphasis on mitral valve prolapse / D. Pellerin, S. Brecker, C. Veyrat // Heart. - 2002. - V. 88 (Suppl. 4). - P. iv20-8.
  171. Anyanwu, A.C. Etiologic classification of degenerative mitral valve disease: Barlow’s disease and fibroelastic deficiency / A.C. Anyanwu, D.H. Adams // Semin Thorac Cardiovasc Surg. - 2007. - V. 19. - № 2. - P. 90-6.
  172. Adams, D.H. Degenerative mitral valve regurgitation: best practice revolution / D.H. Adams, R. Rosenhek, V. Falk // Eur Heart J. - 2010. - V. 31. - № 16. - P. 1958-66.
  173. Guy, T.S. Mitral valve prolapse / T.S. Guy, A.C. Hill // Annu Rev Med. - 2012. - V. 63. - P.277-92.
  174. Griffin, B.P. Myxomatous mitral valve disease / B.P. Griffin // Valvular Heart Disease: A Companion to Braunwald’s Heart Disease / C.M. Otto, R.O. Bonow. - Philadelphia: Saunders/Elsevier, 2009. - P. 243-259.
  175. Малев, Э.Г. Распространенность, патогенетические механизмы и особенности ведения пациентов с про- лапсом митрального клапана: дис. д-ра мед. наук: 14.01.05 / Э.Г. Малев. - Санкт-Петербург, 2014. - 339с.
  176. Theal, M. Prevalence of mitral valve prolapse in ethnic groups / M. Theal, K. Sleik, S. Anand et al. // Can J Cardiol. - 2004. - V. 20. - № 5. - P. 511-5.
  177. Devereux, R.B. Prevalence and correlates of mitral valve prolapse in a population-based sample of American Indians: the Strong Heart Study / R.B. Devereux, E.C. Jones, M.J. Roman et al. // Am J Med. - 2001. - V. 111. - № 9. - P. 679-85.
  178. Flack, J.M. Anthropometric and physiologic correlates of mitral valve prolapse in a biethnic cohort of young adults: the CARDIA study / J.M. Flack, J.H. Kvasnicka, J.M. Gardin et al. // Am Heart J. - 1999. - V. 138. - № 3 Pt 1. - P. 486-92.
  179. Земцовский Э.В. Спортивная кардиология. - СПб.: Гиппократ, 1995. - 448с.
  180. Рудой, А.С. Распространенность и актуальные вопросы военно-врачебной экспертизы пролапса ми- трального клапана / А.С. Рудой, П.П. Пашкевич // Военная медицина. - 2011. - № 1. - С.36-41.
  181. Freed L.A., Benjamin E.J., Levy D. et al. Mitral valve prolapse in the general population: the benign nature of echocardiographic features in the Framingham Heart Study. J Am Coll Cardiol 2002; 40: 1298—304.
  182. Малев Э.Г., Реева С.В., Тимофеев Е.В., Земцовский Э.В. Современные подходы к диагностике и оценке распространенности пролапса митрального клапана у лиц молодого возраста. Российский кардио- логический журнал. 2010. № 1. С. 35-41.
  183. Levine, R.A. Three-dimensional echocardiographic reconstruction of the mitral valve, with implications for the diagnosis of mitral valve prolapse / R.A. Levine, M.D. Handschumacher, A.J. Sanfilippo et al. // Circulation. - 1989. -Vol. 80. - P. 589-98.
  184. Bonow R.O. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines / R.O. Bonow, B.A. Carabello, C. Kanu et al. // Circulation. - 2006. - V. 114. - № 5. - P. e84-231.
  185. Рудой, А.С. Заболевания верхних отделов желудочно-кишечного тракта у лиц молодого возраста, ас- социированные с наследственными нарушениями соединительной ткани (особенности клинической картины, этиологии, патоморфогенеза и прогноза клинического течения): автореф. дис. д-ра мед. наук: 14.01.04; 14.03.09. - ВМедА. - СПб., 2009. - 49 с.
  186. Глотов А.В., Миниевич О.Л. Сосудисто-тромбоцитарный гемостаз при дисплазии соединительной тка- ни и заболеваниях, ассоциированных с ней // Омский научный вестник. - 2005. - №1(30). - С. 107 - 110.
  187. Ягода А.В., Гладких Н.Н., Гладких Л.Н. Особенности адгезивной функции эндотелия при различных клинических вариантах первичного пролапса митрального клапана // Кардиоваскулярная терапия и профилактика. - 2016. - № 1. - С. 45-50.
  188. Гладких Н.Н. Пролапс митрального клапана: клинико-патогенетический анализ с позиции дисплазии соединительной ткани: автореф. дис. д-ра мед. наук / Ставрополь, 2009. - 40 с.
  189. Клеменов А.В. Синдром вегетативной дистонии у юношей с пролапсом митрального клапана. Меди- цинский вестник Северного Кавказа. 2008. №2. С. 90-93.
  190. Bourdarias J.P. Mitral valve prolapse: a severe abnormality? // Arch. Mal. Coeur. Vaiss. 1991 Jul. - Vol. 84 (№ 7). - P. 981-986.
  191. DeGuire S., Gevirtz R., Kawahara Y., Maguire W. Hyperventilation syndrome and the assessment of treatment for functional cardiac symptoms // Am. J. Cardiol. - 1992 Sep 1. - Vol. 70 (№ 6). - P. 673-677.
  192. Wikiecho [Electronic resource]. - Mode of access: http: // www.wikiecho.org/wiki/File: Figure 5 TV.jpg. _ Date of access: 29.01.2016.
  193. Ягода А.В., Пруткова Н.А., Гладких Н.Н. Первичный пролапс митрального клапана у взрослых. Диа- гностика, вопросы диспансеризации и врачебной экспертизы / Учебное пособие. - Ставрополь, Изд: СГМА, 2007. 72 с.
  194. Ikeda T. Mitral valve prolapse in idiopathic ventricular tachycardia: Clinical and electrophysiologic characteristics // J. Cardiol. - 1991. - Vol. 21 (№ 3). - P. 717-726.
  195. Kavey R., Blackman M.S., Sondheimer H.M., Byrum C.J. Ventricular arrhythmias and mitral valve prolapse in childhood // J. Pediatr. St. Louis. - 1984. - Vol. 105 (№ 6). - P. 885890.
  196. Loeys BL, Dietz HC, Braverman AC, et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet. 2010; 47(7): 476-85.
  197. Stoddard MF, Prince CR, Dillon S, et al: Exercise-induced mitral regurgitation is a predictor of morbid events in subjects with mitral valve prolapse // J. Am. Col. Cardiol. - 1995.Vol. 25 (№ 3). - P. 693-699.
  198. Farb A., Tang A.L., Atkinson J.B., et al. Comparison of cardiac findings in patients with mitral valve prolapse who die suddenly to those who have congestive heart failure from mitral regurgitation and to those with fatal noncardiac conditions // Am. J. Cardiol. - 1992 Jul 15. - Vol. 70 (№ 2). - P. 234-239.
  199. Habib G. et al. 2015 ESC Guidelines for the management of infective endocarditis // European heart journal. - 2015. - С. ehv319.
  200. Pocock WA, Bosman CK, Chester E, et al: Sudden death in primary mitral valve prolapse // Am. Heart J. - 1984. - Vol. 107 (№ 2). - P. 378-382.
  201. Allen H, Harris A, Leatham A. Significance and prognosis of an isolated late systolic murmur: a 9 to 22-year follow-up. Br Heart J 1974; 36: 525-32.
  202. Mills P, Rose J, Hollingsworth J, Amara I, Craige E. Long-term prognosis of mitral- valve prolapse. N Engl J Med 1977; 297: 13-8.
  203. Fontana ME, Sparks EA, Boudoulas H, Wooley CF. Mitral valve prolapse and the mitral valve prolapse syndrome. Curr Probl Cardiol 1991; 16: 309 -75.
  204. Devereux RB, Brown WT, Kramer-Fox R, Sachs I. Inheritance of mitral valve prolapse: effect of age and sex on gene expression. Ann Intern Med 1982; 97: 826-32.
  205. Avierinos J.F., Gersh B.J., Melton L.J. 3rd et al. Natural history of asymptomatic mitral valve prolapse in the community. Circulation. 2002; 106(11): 1355-61.46.
  206. Devereux RB, Frary CJ, Kramer-Fox R et al. Cost-effectiveness of infective endocarditis prophylaxis for mitral valve prolapse with or without a mitral regurgitant murmur. Am J Cardiol 1994; 74: 1024-9.
  207. Сторожаков Г.И., Верещагина Г.С., Малышева Н.В. Стратификация риска и выбор клинической тактики у пациентов с пролапсом митрального клапана. Сердечная недостаточность. 2001. № 6. С. 287-290.
  208. Buchner S., Hulsmann M., Poschenrieder F. et al. Variable phenotypes of bicuspid aortic valve disease: classification by cardiovascular magnetic resonance // Heart. 2010. V. 96. № 15. P.1233-1240.
  209. Crawford M.H. Current Diagnosis & Treatment in Cardiology. 2nd ed. NY: McGraw_Hill Companies, 2002. 627 p.
  210. Maruo, A., Higami, T., Obo, H., and Shida, T. Ruptured sinus of Valsalva aneurysm associated with aortic regurgitation caused by hemodynamic effect solely. Eur J Cardiothorac Surg. 2003; 24: 318-319
  211. De Kerchove L., Glineur D., Poncelet A. et al. Repair of aortic leaflet prolapse: a ten_year experience // Eur. J. Cardiothorac. Surg. 2008. V. 34. № 4.P. 785-791.
  212. Ribeiro C.L., Ginefra P., AlbanesiFilho F.M. et al. Prevalence of tricuspid and aortic valve prolapse in patients with mitral valve prolapse // Arq. Bras. Cardiol. 1989. V. 53. № 5. P. 251-255.
  213. Shapiro L.M., Thwaites B., Westgate C. et al. Prevalence and clinical significance of aortic valve prolapse // Br. Heart J. 985. V. 54. № 2. P. 179-183.
  214. Morganroth J., Jones R.H., Chen C.C., Naito M. Two dimensional echocardiography in mitral, aortic and tricuspid valve рrolapse. The clinical problem, cardiac nuclear imaging considerations and a proposed standard for diagnosis // Am. J. Cardiol. 1980. V. 46. № 7. P. 1164-1177.
  215. Boodhwani M, de Kerchove L, Glineur D, Noirhomme P, El Khoury G. Repair of aortic valve cusp prolapse. Multimed Man Cardiothorac Surg. 2009 Jan 1; 2009 (702)
  216. Le Polain de Waroux J.B., Pouleur A.C., Goffinet C. et al. Functional anatomy of aortic regurgitation: accuracy, rediction of surgical repairability, and outcome implications of transesophageal echocardiography // Circulation. 2007. V. 116. № 11. Suppl. P. I264-I269.
  217. El Khoury G, Vanoverschelde JL, Glineur D et al. Repair of aortic valve prolapse: experience with 44 patients. Eur J Cardiothorac Surg. 2004 Sep; 26(3): 628-33.
  218. Allen M.N. Echocardiography. Philadelphia: Lippincott Williams & Wilkins, 1999. 652р.
  219. Земцовский Э.В. Диспластические синдромы и фенотипы. Диспластическое сердце. СПб.: Ольга, 2007; 80 с.
  220. Otto C M. Valvular Heart Disease. 2nd ed. Philadelphia: Saunders, 2004. 624 p.
  221. Schafers H.J., Langer F., Glombitza P. et al. Aortic valve reconstruction in myxomatous degeneration of aortic valves: are fenestrations a risk factor for repair failure? // J. Thorac. Cardiovasc. Surg. 2010. V. 139. № 3. P. 660-664.
  222. Guidelines on the management of valvular heart disease (ESC/EACTS). European Heart Journal 2012; 19(33): 2451-2496.
  223. Fukuda S, Saracino G, Matsumura Y et al. Three-dimensional geometry of the tricuspid annulus in healthy subjects and in patients with functional tricuspid regurgitation: a real-time, 3- dimensional echocardiographic study. Circulation. 2006 Jul 4; 114 (1Suppl): I492-8.
  224. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease) P. Lancellotti, L. Moura, L. A. Pierard et al. European Heart Journal - Cardiovascular Imaging. May 2010, 11 (4): 307-332.
  225. Rogers J.H., Bolling S.F. The tricuspid valve: current perspective and evolving management of tricuspid regurgitation // Circulation. 2009. V. 119.№ 20. P. 2718-2725.
  226. Iaizzo P.A. Handbook of Cardiac Anatomy, Physiology, and Devices. NY: Humana Press, 2009.659 p.
  227. Davies A.O., Mares A., Pool J.L., Taylor A.A. Mitral valve prolapse with symptoms of beta-adrenergic hypersensitivity. AmJournalofMed. 1987; 82(2): 193-200.
  228. Трисветова Е.Л. Малые аномалии сердца (клиника, диагностика, экспертное значение у мужчин моло- дого возраста) / Е.Л. Трисветова. - Минск.: ООО «Ковчег», 2005. - 200с.; ил.
  229. Waller BF, Moriarty AT, Eble JN et al. Etiology of pure tricuspid regurgitation based on anular circumference and leaflet area: analysis of 45 necropsy patients with clinical and morphologic evidence of pure tricuspid regurgitation. J Am CollCardiol. 1986May; 7(5): 106374.
  230. Sattur S, Bates S, Movahed MR. Prevalence of mitral valve prolapse and associated valvular regurgitations in healthy teenagers undergoing screening echocardiography. ExpClinCardiol. 2010 Spring; 15(1): e13-5.
  231. Van Son JA, Miles CM, Starr A. Tricuspid valve prolapse associated with myxomatous degeneration. Ann Thorac Surg. 1995 May; 59(5): 1237-9.
  232. Малев Э.Г., Земцовский Э.В. Пролапсы трикуспидального, аортального и пульмонального клапанов. Ультразвуковая и функциональная диагностика. 2011. №3. С. 84-92.
  233. Prabhu M.R. Trans-esophageal echocardiography for tricuspid and pulmonary valves. AnnCardAnaesth. 2009; 12(2): 167.
  234. Taylor М.А. Tricuspid Valve and Pulmonic Valve. - [Electronic resource]. - Mode of access: https: // www. scahq.org/sca3/events/2012/echo/fundamentals/submissions/tue/Tricuspid%20Valve%20a nd%20 Pulmonic%20Valve%20-%20Taylor.pdf. - Date of access: 27.01.2016
  235. Nath J., Fornes P., Heudes D., Fuzellier J.F. et al.Correlation between clinical and histologic patternsof degenerative mitral valve insufficiency: a histomorphometric study of 130 excised segments // Cardiovasc. Pathol. 1999. V. 8. № 2. P. 81-92.
  236. Raichlen JS, Brest AN. Tricuspid valve prolapse. Cardiovasc. Clin. 1987; 17(2): 97109.
  237. Земцовский Э.В. Диспластические синдромы и фенотипы. Диспластическое сердце. СПб.: Ольга, 2007. 80 с.
  238. McCarthy PM, Bhudia SK, Rajeswaran Jetal. Tricuspid valve repair: durability and risk factors for failure. J Thorac Cardiovasc Surg. 2004; 127: 674—685.
  239. ACC/AHA 2006 guidelines for the management ofpatients with valvular heart disease: a report of theAmerican College of Cardiology/American HeartAssociation Task Force on Practice Guidelines(writing Committee to Revise the 1998 guidelinesfor the management of patients with valvularheart disease) developed in collaboration with theSociety of Cardiovascular Anesthesiologists endorsed by the Society for CardiovascularAngiography and Interventions and the Society ofThoracic Surgeons // J. Am. Coll. Cardiol. 2006. V. 48. № 3. P. e1-e148.
  240. Guidelines on the management of valvular heart disease (ESC/EACTS). European Heart Journal 2012; 19 (33): 2451-2496. Европейского Общества Кардиологов / Европейской Ассоциации Кардиоторакаль- ной Хирургии (ESC/EACTS) 2012 года
  241. Трисветова Е.Л., Юдина О.А. Анатомия малых аномалий сердца. Минск: «Белпринт», 2006. - 104 с.
  242. Lancellotti P., Tribouilloy C., Hagendorff A. et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 1: aortic and pulmonary regurgitation (native valve disease) // Eur. J. Echocardiogr. 2010. V. 11. № 3. P. 223-244.
  243. Virtual Transesophageal Echocardiography. Toronto General Hospital Department of Anesthesia and Pain Management. - [Electronic resource]. - Mode of access: http: // pie.med.utoronto.ca/TEE/index.htm- Date of access: 27.01.2016
  244. De Backer J. et al. A critical analysis of minor cardiovascular criteria in the diagnostic evaluation of patients with Marfan syndrome // Genet. Med. — 2006. — №8. — P. 401-408.
  245. De Backer J. Cardiovascular characteristics in Marfan syndrome and their relation to the genotype // Verh. K. Acad. Geneeskd. Belg. 2009. V. 71.№6. P. 335-371.
  246. Oosterhof T., Hazekamp M.G., Mulder B.J. Opportunities in pulmonary valve replacement. Expert Rev CardiovascTher. 2009; 7(9): 1117-1122.
  247. Земцовский Э.В., Красовская Ю.В., Парфенова Н.Н. и др. Асимметрия смыкания аортальных полулу- ний - эхокардиографический феномен или клинически значимая аномалия сердца? // Кардиология СНГ - 2006. - Т. 3, №2 - с. 135-140
  248. Mookadam F, Thota VR, Lopez AM, Emani UR, Tajik AJ.Unicuspid aortic valve in children: a systematic review spanning four decades. J Heart Valve Dis. 2010; 19(6): 678-83.
  249. Friedman T, Mani A, Elefteriades JA. Bicuspid aortic valve: clinical approach and scientific review of a common clinical entity. Expert Rev CardiovascTher. 2008; 6(2): 235-48.
  250. Roberts WC, Ko JM. Weights of individual cusps in operatively-excised stenotic three- cuspid aortic valves. Am J Cardiol. 2004; 94(5): 681-4.
  251. Tutarel O.Quadricuspid aortic valves: a review. ClinCardiol. 2003; 26(5): A24.
  252. Гнусаев С.Ф., Белозеров Ю.М. Эхокардиографические критерии диагностики и классификации малых аномалий сердца у детей. Ультразвуковая диагностика. 1997. №3. С. 21-27.
  253. Clinical significance of transverse pericardial - coronary artery // 78 steps Health Journal [Electronic resource]. - Mode of access: http: // www.78stepshealth.us/coronary-artery/s- fje.html- Date of access: 24.01.2016.
  254. Vollebergh F.E., Becker A.E. Minor congenital variations of cusp size in tricuspid aortic valves; possible link with isolated aortic stenosis // Br Heart J. - 1977. - Vol. 39 - рр. 10061011
  255. Земцовский Э. В. Наследственные нарушения соединительной ткани в кардиологии. Диагностика и лечение: Российские рекомендации (I пересмотр). Рос. кардиолог. общ-во; ком. экспертов. Рос. кард. журнал. 2013; 99(1): 32 с. - Прил. №1.
  256. Красовская Ю. В. Асимметрия трехстворчатого клапана как малая аномалия сердца. Автореф. дисс. канд. мед. наук. СПб., 2007. - 20 с.
  257. Парфенова Н.Н. Клинико-ультразвуковые сопоставления у лиц молодого возраста с синдромом дис- плазии соединительной ткани сердца: автореф. дис. к.м.н. СПб., 2002. — 22с.
  258. Павловский В.А., Чечитова Ю.С., Парфенова Н.Н., Земцовский Э.В. Математическое моделирование механического стресса, возникающего в процессе функционирования асимметричных створок аор- тального клапана. Вестник Санкт-Петербургского университета. Серия 10: Прикладная математика. Информатика. Процессы управления. 2008. № 4. С. 72-79.
  259. Серговенцев А.А. Кальцинированный аортальный стеноз: итоги 15-летнего изучения в России // РМЖ (Кардиология) - 2013. - № 27.
  260. Митрофанова Л.Б., Ковальский Г.Б. Морфологическая характеристика и дифференциальная диагно- стика заболеваний клапанов сердца. Архив патологии. 2007. Т. 69. № 1. С. 24-31.
  261. Otto CM. Calcification of bicuspid aortic valves. Heart. 2002; 88(4): 321-2.
  262. Gilon D, Cape EG, Handschumacher MD, et al. Effect of three-dimensional valve shape on the hemodynamics of aortic stenosis: three-dimensional echocardiographic stereolithography and patient studies. J Am CollCardiol. 2002; 40(8): 1479-86.
  263. Fernandes SM, Sanders SP, Khairy P et al.Morphology of bicuspid aortic valve in children and adolescents. J Am CollCardiol. 2004; 44(8): 1648-51.
  264. Хасанова С.И. Роль соединительнотканной дисплазии в формировании склеро- дегенеративных по- ражений аортального клапана. Диссерт. канд. мед. наук - 2010. - 151 с.
  265. Земцовский Э.В., Парфенова Н.Н., Красовская Ю.В. и др. Расчет асимметрии трех- створчатого аор- тального клапана. Свидетельство об официальной регистрации программы для ЭВМ №2007615221.
  266. Calleja A. et al. Automated Quantitative 3-Dimensional Modeling of the Aortic Valve and Root by 3-Dimensional Transesophageal Echocardiography in Normals, Aortic Regurgitation, and Aortic Stenosis: Comparison to Computed Tomography in Normals and Clinical Implications. Circ Cardiovasc Imaging. 2013; 6: 99-108.
  267. Земцовский Э.В., Красовская Ю.В., Парфенова Н.Н., Антонов Н.Н. Критерии диагностики и клиниче- ская оценка асимметрии терхстворчатого аортального клапана Тер. Архив 2006 № 12 с. 50 - 55
  268. Парфенова Н.Н., Красовская Ю.В., Хасанова С.И. и др. Асимметрия аортальных полулуний - критерии эхокардиографической диагностики // Вестник Санкт- Петербургского университета. Серия 11: Меди- цина. - 2010. - № 1. - с. 30-38.
  269. Guidelines on the management of valvular heart disease (ESC/EACTS). European Heart Journal 2012; 19 (33): 2451-2496.
  270. Merante A, Gareri P, Castagna A, et al. Transient cerebral ischemia in an elderly patient with patent foramen ovale and atrial septal aneurysm. Clinical Interventions in Aging. 2015; 10: 1445-1449. doi: 10.2147/CIA. S80190.
  271. Mas JL, Arquizan C, Lamy C, et al; Patent Foramen Ovale and Atrial Septal Aneurysm Study Group. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med. 2001; 345(24): 1740-1746.
  272. Mattioli AV, Aquilina M, Oldani A. et al. Atrial septal aneurysm as a cardioembolic source in adult patients with stroke and normal carotid arteries. A multicentre study. Eur Heart J. 2001; 22(3): 2618.
  273. Rigatelli G, Aggio S, Cardaioli P, et al. Left atrial dysfunction in patients with patent foramen ovale and atrial septal aneurysm: an alternative concurrent mechanism for arterial embolism? JACC CardiovascInterv. 2009; 2(7): 655-62.
  274. van Son JA, Miles CM, Starr A. Tricuspid valve prolapse associated with myxomatous degeneration. Ann Thorac Surg. 1995 May; 59(5): 1237-9.
  275. Emine BS, Murat A, Mehmet B et al. Flail mitral and tricuspid valves due to myxomatous disease. Eur J Echocardiogr. 2008 Mar; 9(2): 304-5.
  276. Kyndt F, Gueffet JP, Probst V et al. Mutations in the gene encoding filamin A as a cause for familial cardiac valvular dystrophy. Circulation. 2007 Jan 2; 115(1): 40-9.
  277. Онищенко Е.Ф. Клинико-эхокардиографическая характеристика внутрипо- лостных структур сердца в норме и при патологии. Дисс. д.м.н. — СПб. 2000.404 с.
  278. Blankenship JC. Migraine and patent foramen ovale: headache for patient and cardiologist. Catheter Cardiovasc Interv. 2010 Mar 1; 75(4): 505-6.
  279. Gersony WM, Gersony DR. Migraine headache and the patent foramen ovale. Circulation. 2010 Mar 30; 121(12): 1377-8.

Для продолжения работы требуется Registration
На предыдущую страницу

Предыдущая страница

Следующая страница

Список литературы
На предыдущую главу Предыдущая глава
оглавление
Следующая глава

Table of contents

Данный блок поддерживает скрол*